Axis-Aligned Bounding Box

The standards are developed by an expert committee (comprising physicians, laboratory technologists, and ethicists) and are updated periodically. Facilities applying for accreditation prepare by implementing established documents and processes, and subsequently undergo an on-site inspection by an AABB audit team. Accreditation is typically renewed every two years, making compliance maintenance an ongoing process.

Overview and Background

AABB (American Association of Blood Banks)originally known as an organization that set standards for blood banks in the United States. Currently, this organization has grown intoAssociation for the Advancement of Blood & Biotherapies, an international non-profit organization focused on improving the quality of blood transfusion services and cell-based therapies.

Benefits of Obtaining Accreditation

Achieving AABB accreditation demonstrates to hospitals, donors, and partners that transfusion or cellular therapy services meet international standards for safety and quality. This enhances the confidence of patients and providers; for example, prospective donors are more assured when a blood bank holds AABB accreditation.

AABB was established in 1957 and has since become a leader in the standardization of blood transfusion practices. The organization develops operational standards for blood banks and transfusion units, and provides accreditation programs for hospitals and blood centers in many countries.

Beyond public trust, accreditation aids organizations in optimizing operational processes (e.g., documentation, training, and facility enhancements), which in turn leads to improved service quality and heightened preparedness for regulatory inspections.

As the field of cell therapy has evolved, AABB's scope expanded beyond blood transfusions to include cell and tissue products, such as cord blood banks and cell transplantation programs. Currently, AABB serves as an international benchmark for quality and safety standards in cellular and tissue products.

In some countries, the use of blood or transplant products from AABB-accredited banks is recommended or required. Accreditation is also often complemented by other certifications (e.g., ISO 9001), and this combination strengthens the facility's position as a provider of high-quality services.

The need for these international standards stems from a growing awareness of transfusion risks—such as the transmission of blood-borne infectious diseases or technical issues like blood type incompatibility. By establishing clear and consistent standards, AABB helps mitigate these risks and enhances public confidence in blood services and cell therapies.

In summary, AABB accreditation not only protects patients and donors but also enhances organizational reliability and helps expedite and facilitate international licensing or collaboration processes.

Donor Eligibility and Consent

Key Requirements and Standards

At a cord blood bank, the provider must obtain informed consent from the donor mother, and conduct a health history assessment and infectious disease testing to ensure sample safety.

According to AABB standards, donor screening methods and the panel of required viral tests (e.g., HBV, HCV, HIV) are specified in detail; compliance with these requirements helps ensure the safety of umbilical cord blood.

To obtain AABB accreditation, a facility must implement practices consistent withAABB StandardsThis standard contains detailed requirements for transfusion services, as well as cell-related and biological therapy services, and is reviewed periodically by an expert panel.

Procedure for Collection and Processing

Evaluation and Assessment of Donor Eligibility

Procedures for umbilical cord blood collection, cell processing, and cryopreservation are documented in SOPs and performed by trained staff.

Facilities such as blood banks or cord blood banks must obtain informed consent from donors, conduct comprehensive health screening, and perform laboratory testing for infections. AABB establishes clear guidelines regarding donor interviews and mandatory viral testing (e.g., HBV, HCV, HIV, syphilis) to ensure the safety of biological materials stored and used for transplantation.

Compliance with aseptic practices, the performance of quality checks such as cell count measurements and culture tests, and the accuracy of sample labeling are part of the standards to ensure traceability and quality.

Procedure for Collection and Processing

Facilities and Equipment Requirements

The procedures, from collection and processing to cryopreservation, are standardized within Standard Operating Procedures (SOPs) and executed by trained and certified staff. Compliance with aseptic practices, cell count and viability measurements, and quality control checks are performed to ensure the quality and traceability of each sample.

This standard also includes facility criteria such as clean rooms, liquid nitrogen tanks, temperature monitoring, backup power supplies, and alarm systems — all necessary to ensure safe cell storage conditions.

Facilities and Equipment Requirements

Quality Management System

The standard encompasses facility criteria such as clean rooms with particulate and microorganism control, liquid nitrogen tanks with backup systems, continuous temperature monitoring, alarm systems, uninterruptible power supply (UPS), and environmental documentation — all essential for the safe storage of cells and tissues under optimal conditions.

Documentation, record-keeping, staff training, internal audits, and deviation management are established in accordance with AABB Standards as part of the quality management system.

Despite its resemblance to ISO quality systems, AABB incorporates more field-specific requirements (e.g., precision control in transfusion laboratories, transportation procedures for transplant products).

Quality Management System

Comprehensive documentation, record keeping, ongoing staff training, internal audits, and incident management must be established in accordance with AABB Standards. While similar to ISO QMS (Quality Management System), AABB emphasizes more specific aspects for transfusion services and cellular products — such as laboratory precision control, transportation procedures for transplant products, and biosafety protocols.

Transportation and Delivery

The procedures for providing stored umbilical cord blood to future patients are also standardized.

Transportation and Product Delivery

The process from requisition to delivery, including temperature control during transit, confirmation of receipt, and completeness of documentation, is meticulously detailed to ensure secure and verifiable delivery to the transplant center.

The standards also govern the workflow for the transfer of units (blood or cellular products) to the recipient: from the official request, appropriate packaging, and temperature control during shipment (cold chain management), through to confirmation of receipt and the necessary documentation, all to ensure the products arrive at the transplant center safely, verified, and in optimal condition for clinical use.

AABB standards cover a range of services such as blood transfusions and cell therapy products, but all of them aim toprotecting the safety of patients and donors and ensuring the quality and effectiveness of products (blood or cells).

Significance and Benefits of Compliance

Each standard is developed by a committee of experts (physicians, laboratory technologists, ethicists) and revised periodically to reflect advancements in science and technology. Facilities applying for accreditation prepare their operations to meet these standards and will undergo an on-site inspection by an AABB team.

During the inspection, the audit team will review documents, interview staff, and observe work processes to ensure there are no non-conformities. If the inspection findings meet the standards, accreditation will be granted.

For Blood Banks and Medical Facilities

Achieving AABB accreditation demonstrates to hospitals, donors, and clinical partners that transfusion services or cellular therapies meet international standards for safety and quality. This enhances public trust and strengthens the facility's credibility among patients, donor families, and healthcare professionals.

The accreditation is subject to biennial renewal, thereby requiring facilities to ensure ongoing adherence to standards.

The accreditation process also drives operational improvements within the facility; by aligning workflows, documentation, staff education, and equipment maintenance with established standards, the overall quality of the organization improves. AABB accreditation is often combined with other certifications (such as ISO 9001), creating a synergistic effect that reinforces the facility's position as a high-quality service provider.

The Significance and Benefits of Accreditation

The meaning of obtaining AABB accreditation is that a hospital or bank can guarantee thatThe transfusion and cell therapy services at the facility meet international standards for safety and quality..

For Patients and Transplant Recipients

This enhances the sense of security for patients and donors, and strengthens the facility's credibility. For example, if a cord blood bank is AABB-accredited, prospective mothers will be confident that their cord blood units will be properly managed, and transplant physicians will have greater confidence in the quality of those units.

Patients receiving blood transfusions or cellular products from an AABB-accredited facility can be assured that these products have been screened, tested, and processed to the highest international safety standards. This significantly minimizes the risk of infectious disease transmission, microbiological contamination, or products with low viability, thereby improving clinical outcomes and reducing transplant complications.

Indeed, in some countries, for specific clinical applications, it is recommended or even mandated that the cord blood utilized originates from an AABB-accredited bank. Consequently, AABB accreditation serves as a mark of quality that enhances a facility's competitiveness in the eyes of both patients and healthcare professionals.

The Impact of Accreditation on Products, Services, and Beneficiaries

Furthermore, the accreditation process drives operational improvements within the facility. By aligning workflows, documentation, staff training, and equipment enhancements with established standards, the organization's overall quality is significantly improved. Given the biennial renewal inspections, facilities are continuously motivated to maintain and enhance compliance.

The outcomes include the establishment of an internal audit culture and continuous training, enhanced staff competency, prevention of medical incidents, operational efficiency, and enhanced inter-departmental collaboration. Facilities holding multiple accreditations (such as ISO 9001 and AABB) often realize synergistic benefits between quality management and specific medical standards, leading to enhanced service delivery.

Blood products and cells processed in accordance with AABB Standards exhibit superior quality. The risk of contamination is significantly reduced, cellular viability and function are better preserved, and clinical performance is significantly enhanced. For instance, blood products from AABB-accredited centers typically undergo rigorous viral screening, accurate blood group verification, and standardized storage and delivery, thereby reducing the risk of infection for transfusion recipients.

Briefly, AABB accreditation provides international quality assurance, enhances patient and donor confidence, and fosters organizational maturity.

In umbilical cord blood transplantation, units provided by accredited banks typically meet stringent criteria for total nucleated cell count (TNC) and viability, thereby contributing to improved transplant outcomes, more rapid hematopoietic recovery, and a reduced incidence of graft-versus-host disease (GVHD).

The Impact of Accreditation on Products, Services, and Beneficiaries

The direct beneficiaries of this accreditation includePatients receiving transfusions or cell therapy dan donor who provides blood or tissueProducts from accredited facilities are managed under strict standards, ensuring patients receive safer and more effective care.

For donors and their families, AABB accreditation ensures that their samples are diligently screened and properly managed throughout the supply chain. Donor selection processes, secure sample handling, personal data protection, and health follow-up are integral to these standards, providing donors with the assurance that their contributions are securely safeguarded and will effectively benefit recipients.

For example, blood products from AABB-accredited centers generally undergo rigorous viral screening and blood group verification, as well as appropriate storage and delivery, thereby reducing the risk of infection for transfusion recipients.

In cord blood transplantation, units provided by accredited banks typically meet cell count and viability criteria, thereby contributing to improved transplant outcomes and a reduction in complications.

Consequently, AABB accreditation enhances public trust in transfusion and cell therapy services, encourages donor participation, and strengthens the healthcare system's preparedness for routine transfusion needs and emergency situations, such as mass casualty blood requirements.

For donors, accreditation ensures that their samples are properly examined and managed. The standards encompass donor selection processes, sample handling, and personal data protection, thereby providing donors with the assurance that their contribution is secure and valuable.

Consequently, accreditation enhances public confidence in transfusion and cell therapy services, promotes donor engagement, and reinforces the readiness of the healthcare system, including its response to emergency situations such as mass transfusion needs.

International Organizations and Related Regulatory Authorities

International Organizations and Related Regulatory Bodies

Although AABB originated in the United States, its standards and certification system have been widely recognized and adopted internationally.

The U.S. Food and Drug Administration (FDA) regulates blood service providers in its country; however, AABB Standards and FDA regulations are complementary. AABB certification often assists facilities in preparing for FDA inspections and maintaining regulatory compliance.

AABB - Association for the Advancement of Blood & Biotherapies

The FDA also collaborates with the AABB, for instance, by sending staff to the annual AABB conference and incorporating AABB expert input into guideline development. Furthermore, the American Red Cross and most state-level blood centers generally hold AABB certification, making these standards de facto in domestic healthcare practice.

AABB is an international non-profit organization based in the United States, with members and influence extending to over 100 countries. AABB Standards are developed by an expert committee comprising physicians, laboratory technologists, ethicists, and clinical practitioners from various countries.

Internationally, AABB collaborates with blood service organizations in various countries.

FDA (Food and Drug Administration) - United States

For instance, several blood centers and cord blood banks in Canada, Singapore, and various Middle Eastern countries have obtained AABB certification. Japan also provides examples of private cord blood banks that have received AABB certification, reflecting their commitment to achieving international quality standards in addition to fulfilling domestic licensing requirements.

The FDA is the regulatory body that oversees blood services in the United States. AABB Standards and FDA regulations are complementary — facilities that comply with AABB Standards typically also meet FDA regulatory requirements. Collaboration between AABB and FDA includes information exchange, input in guideline development, and inspection coordination.

In the same field, other international certifications exist, such as FACT (Foundation for the Accreditation of Cellular Therapy) and JACIE (a European cellular therapy certification), but AABB is positioned as a more comprehensive organization, particularly for transfusion and biotherapies. The WHO also references AABB's initiatives in promoting safe transfusions, and there is an impetus to adopt frameworks consistent with AABB standards when developing guidelines or assisting developing countries.

For example, the WHO document on "quality systems for safe blood" recommends that countries use international standards such as AABB as a model when establishing quality assurance programs.

World Health Organization (WHO)

WHO recommends the implementation of international standards, such as AABB, in the development of quality systems for safe blood. The WHO document "Quality Systems for Safe Blood" encourages countries to utilize international standards like AABB as a model when establishing or enhancing their national quality assurance programs.

Essentially, despite being an industry organization, AABB effectively functions as an international certification body, networking with regulatory authorities such as the FDA, public bodies such as the WHO, and other certification organizations. While AABB certification is pursued at the facility level, these collective efforts establish a safety network for blood and cell therapy services, both domestically and internationally, complementing and strengthening public regulation.

Going forward, AABB will continue to develop standards from a global perspective and contribute to enhancing the reliability of healthcare services.

FACT (Foundation for the Accreditation of Cellular Therapy)